About Datapharm
Datapharm is a company based in Leatherhead (United Kingdom) founded in 1977 by Simon Abrams. The company has 34 employees as of January 31, 2022. Datapharm offers products and services including emc Regulatory, emc Compliance, emc Market Access, and emc Market Intelligence. Datapharm operates in a competitive market with competitors including MetricStream, RLDatix, Radar Healthcare, Mighty and Advarra, among others.
- Headquarter Leatherhead, United Kingdom
- Employees 34 as on 31 Jan, 2022
- Founders Simon Abrams
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Datapharm Limited
- Date of Incorporation 26 Mar, 2018
- Jurisdiction LEATHERHEAD, SURREY, ENGLAND
-
Annual Revenue
$7.53 M (USD)27as on Dec 31, 2022
-
Net Profit
$618.07 K (USD)-53as on Dec 31, 2022
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
34
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Datapharm
Datapharm offers a comprehensive portfolio of products and services, including emc Regulatory, emc Compliance, emc Market Access, and emc Market Intelligence.
Delivers product safety information in required formats.
Ensures up-to-date and accurate product information for teams.
Manages information flow in supply chains for stakeholders.
Tracks HCP engagement and medicine information changes.
People of Datapharm
Unlock access to complete
Funding Insights of Datapharm
Investors in Datapharm
Datapharm has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CGE Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CGE Partners is engaged in private equity investments.
|
Locked | Locked | Locked |
Investor details for Datapharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Datapharm
Investment portfolio details for Datapharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Datapharm
Detailed financials for Datapharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Datapharm Comparisons
Peer comparison for Datapharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Datapharm
Datapharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MetricStream, RLDatix, Radar Healthcare, Mighty and Advarra, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based regulatory solutions are provided for financial institutions.
|
|
| Locked | Locked | Locked |
GRC software solutions for healthcare risk management are delivered.
|
|
| Locked | Locked | Locked |
Administrative tasks are managed digitally for healthcare providers.
|
|
| Locked | Locked | Locked |
Software solutions for legal funding management are provided.
|
|
| Locked | Locked | Locked |
Global research compliance services including IRB and consulting are provided.
|
|
| Locked | Locked | Locked |
SaaS-based compliance monitoring for healthcare exclusions is provided.
|
Detailed competitors of Datapharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Datapharm
Complete news archive for Datapharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Datapharm
Datapharm was founded in 1977 and raised its 1st funding round 45 years after it was founded.
Datapharm is headquartered in Leatherhead, United Kingdom.
Simon Abrams is the current CEO of Datapharm. They have also founded this company.
As of Jan 31, 2022, the latest employee count at Datapharm is 34.
Annual revenue of Datapharm is $7.53M as on Dec 31, 2022.
Datapharm was established in 1977 and operates from Leatherhead, United Kingdom. Software solutions for regulatory and compliance needs in the pharmaceutical and healthcare sectors are developed and supplied. The electronic medicines compendium (EMC) is included among the offerings, supporting adherence to regulations while facilitating access to information on medicines for healthcare professionals and patients.
Datapharm's top competitors include Advarra, RLDatix and ProviderTrust.
Datapharm offers emc Regulatory, emc Compliance, emc Market Access, and emc Market Intelligence.
Datapharm has 1 investor. Key investors include CGE Partners.